Dolutegravir-Associated Hyperglycemia in a Patient on Highly Active Antiretroviral Therapies

Abstract

Highly active antiretroviral medications have been reported to cause hyperglycaemia in the literature especially the protease inhibitor. We however report a case of dolutegravir-associated hyperglycaemia which is an integrase strand transfer inhibitor.

Keywords

• antiretroviral therapies
• dolutegravir
• human immunodeficiency